Archimed, a leading European strategic and financial partner for Healthcare companies, has acquired a majority stake in Soest Medical Group (SMG), the holding company of Eurotape and Somed. The existing management team of SMG: Hans van der Meer (CEO), Miguel Pablo (CCO) and former owner Jan Holtrop, reinvested their shares alongside Archimed as part of the transaction. SMG had emphasised that as a result of this transaction, they will continue to provide to our customers the high level of service and differentiated products that has characterised Eurotape and Somed so successfully over the last years. Eurotape and Somed have developed a sustainable market leadership position in the medical adhesives' space in Europe and beyond and will now have the chance to extend to new segments of the market with the support of specialist investors, such as Archimed who are able to provide access to their valuable international healthcare network.
“ArchiMed’s deep knowledge and connections throughout the global healthcare sector will help us diversify our products and expand our sales to new geographies,” says Hans Van Der Meer, chief executive of SMG. “They’ll accelerate our growth substantially.”
CEPTON strategies was in charge of the Strategic Due Diligence. Jean Reboullet (Managing Partner) and Camille Bertin (Manager) led a team of two additional consultants.
